Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Drug laws revolution set for UK

Nick Paton Walsh and Gaby Hinsliff

The Observer

Sunday 17 Feb 2002

---

Cannabis on NHS under radical scheme

Cannabis should be decriminalised in an Amsterdam-style revolution on
the streets of Britain, an influential group of MPs will recommend in a
landmark report.

A seven-month investigation by the Home Affairs Select Committee,
conducted at Downing Street's request, concludes that ecstasy should be
downgraded and prosecutions for possession of cannabis ended.

The report, to be published this spring, will be seen as an
authoritative milestone in the fierce debate over legalisation. It comes
as cannabis treatments are to be prescribed on the NHS to multiple
sclerosis sufferers, in a radical step to be revealed tomorrow.

The Government will ask its medicines watchdog, the National Institute
of Clinical Excellence (Nice), to issue guidelines for doctors on
prescribing two cannabis derivatives - one a capsule, the other a spray
used under the tongue - made by drug companies which have isolated the
active ingredients of marijuana.

Neither results in a 'high', and patients will not be given the option
of smoking street cannabis. But the Home Office is watching the move
with interest. 'There is a general feeling that this would be part of
the process of breaking down the barriers of resistance to the way
cannabis is treated,' said one Whitehall source.

Downing Street, which has been adamant that there will be no
decriminalisation of soft drugs, is expected to give a cautious welcome
to the report but to oppose ecstasy, a class A drug, being downgraded to
Class B.

Home Secretary David Blunkett recently downgraded cannabis from B to C,
which still carries a two-year sentence for possession but in effect
means personal use rather than dealing will be tolerated. The committee
backs a further step to a model similar to that in Holland, where dope
is as openly consumed in cafes as coffee.

It also wants wider prescription of heroin on the NHS to addicts, a
greater emphasis on 'harm reduction strategies' and a review of drug
treatment in prisons.

A confidential report is circulating among senior officers at Scotland
Yard on the success of a pilot scheme under which police informally
caution people caught in possession of cannabis and then let them go, as
opposed to a formal caution at a police station. During the six-month
scheme, in Lambeth, London, police gained 1,400 hours of working time,
and a significant rise in arrests for Class A drugs was recorded.
Reformers will seize on the news as proof that relaxed approaches to
cannabis can actually help fight crime.

A source close to the committee said: 'The chairman, Chris Mullin MP, is
set on these recommendations, and the majority of the committee is
behind him.' Two members are thought to harbour more conservative views.

Blair has made clear he does not want Labour to be seen as 'soft on
drugs', limiting potential for legalisation. However, insiders expect
that, even if Blunkett insists on cannabis remaining a Class C drug,
police will be told informally not to prosecute for possession.

Lord Falconer, the Housing Minister and a close Blair ally, will meet
the Home Office Ministers John Denham and Bob Ainsworth on Tuesday to
'brainstorm' ideas for drug law reform.

Roger Howard, chief executive of the government-funded charity
Drugscope, said: 'For such an influential body to be suggesting such
significant reforms is indicative of the pressing need for change.'

But John Ramsey, a toxicologist at St George's Hospital Medical School
in London, questioned whether heroin on prescription would help to break
an addict's 'habit of injection'. He added: 'We should not be telling
people that MDMA (ecstasy) is now considered a safe drug.'

The Department of Health will publish a consultation paper tomorrow on
cannabis derivatives dronabinol, made by Solvay Healthcare, and a
cannabis-based medicinal extract spray made by GW Pharmaceuticals. Both
are still undergoing trials and are unlikely to be licensed for use
until 2004.

nick.walsh@observer.co.uk

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!